Novel 2-(4-methylsulfonylphenyl)pyrimidine derivatives as highly potent and specific COX-2 inhibitors

  • Bioorg Med Chem. 2008 Mar 1;16(5):2183-99. doi: 10.1016/j.bmc.2007.11.079.
Aurelio Orjales  1 ,  Ramón Mosquera ,  Beatriz López ,  Roberto Olivera ,  Luis Labeaga ,  M Teresa Núñez
Affiliations
  • 1. Department of Research, Faes Farma S.A., Máximo Aguirre 14, 48940 Leioa, Spain.
PMID: 18158247 DOI: 10.1016/j.bmc.2007.11.079
Abstract

New series of 2-(4-methylsulfonylphenyl) and 2-(4-sulfamoylphenyl)pyrimidines were synthesized and evaluated for their ability to inhibit cyclooxygenase-2 (COX-2). COX-1 and COX-2 inhibitory activity of these compounds was determined using purified enzyme (PE) and human whole blood (HWB) assays. Extensive structure-activity relationship (SAR) work was carried out within these series, and a wide number of potent and specific COX-2 inhibitors were identified (HWB COX-2 IC(50)=2.4-0.3nM and 80- to 780-fold more selective than rofecoxib).

Products